The story has been updated with perspectives from Teladoc after initial publication. Zane Burke was at J.P. Morgan’s annual healthcare conference earlier this year touting Quantum Health, which he ...
Chronic disease management company Livongo is collaborating with Voluntis, the Paris, France-based company that develops companion apps for medical devices, to offer an integrated program, insulin ...
Chronic care management company Livongo has inked a deal with the U.S. government, giving federal employees insured by the government with Type 1 or Type 2 diabetes access to the digital program. The ...
Livongo, a Mountain View, Calif.-based digital health platform for chronic disease management, signed an agreement to provide its diabetes management program to eligible members of the Federal ...
Livongo Health on July 15 announced more details regarding its upcoming initial public offering, according to Fortune. The digital health company plans to raise around $230 million and offer 10.7 ...
Teladoc is likely to report a large charge in the first quarter of 2022, according to a 10-K filing. The charge would show that Livongo, a chronic-care company that Teladoc acquired, is losing value.
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. About a ...
With 42.8% YoY revenue growth to $1B by 2022, BetterHelp alone may be worth a considerable part of TDOC's current enterprise value of $5.47B. While the management does not disclose its earnings by ...
Telehealth specialist Teladoc Health (TDOC 1.79%) acquired digital health management company Livongo in October 2020. The acquisition brought Livongo's programs for remotely managing conditions like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results